Expired Tender South Korea ICB TOT Ref. 139420940

Research service for establishing reasonable Tender - 139420940

Tender notice from South Korea, published on 12 Apr 2026.

Executive Summary

The HEALTH INSURANCE REVIEW AND ASSESSMENT SERVICE has issued a Tender notice for the procurement of a Research service for establishing reasonable cost-effectiveness evaluation standards for new drugs and health insurance. The project involves evaluating the cost-effectiveness of new drugs and establishing standards for health insurance listings. The in the South Korea. This Tender notice was published on 12 Apr 2026 and is scheduled to close on 14 Apr 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 139420940, while the tender notice number is 2026-104 and Register on the platform.

Key facts

Summary
Research service for establishing reasonable cost-effectiveness evaluation standards for new drugs and health insurance. The project involves evaluating the cost-effectiveness of new drugs and establishing standards for health insurance listings. The
TOT Ref. No.
139420940
Document Ref. No.
2026-104
Country
South Korea
Notice type
Tender
Competition
ICB
Publication date
12 Apr 2026
Bid deadline
14 Apr 2026
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Research service for establishing reasonable cost-effectiveness evaluation standards for new drugs and health insurance. The project involves evaluating the cost-effectiveness of new drugs and establishing standards for health insurance listings. The contract period is up to 6 months from the contract date, and the project budget is KRW 60, 000, 000 (including value-added tax).

Documents

Tender Notice
Login to view

South Korea Public Procurement Intelligence

Frequently asked questions

The bid deadline for Research service for establishing reasonable cost-effectiveness evaluation standards for new drugs and health insurance. The project involves evaluating the cost-effectiveness of new drugs and establishing standards for health insurance listings. The was 14 Apr 2026. Bidding is closed.

This tender has been issued by HEALTH INSURANCE REVIEW AND ASSESSMENT SERVICE in South Korea.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 139420940. The purchaser document reference is 2026-104.

Browse other tenders from South Korea or search by relevant keywords and CPV classification.